Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Non-Current Debt: 2021-2022

Historic Non-Current Debt for Candel Therapeutics (CADL) over the last 2 years, with Dec 2022 value amounting to $20.2 million.

  • Candel Therapeutics' Non-Current Debt fell 28.74% to $14.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $14.3 million, marking a year-over-year decrease of 28.74%. This contributed to the annual value of $20.2 million for FY2022, which is 3507.50% up from last year.
  • Latest data reveals that Candel Therapeutics reported Non-Current Debt of $20.2 million as of FY2022, which was up 3,507.50% from $560,000 recorded in FY2021.
  • Candel Therapeutics' 5-year Non-Current Debt high stood at $20.2 million for FY2022, and its period low was $560,000 during FY2021.
  • In the last 2 years, Candel Therapeutics' Non-Current Debt had a median value of $10.4 million in 2021 and averaged $10.4 million.
  • Data for Candel Therapeutics' Non-Current Debt shows a peak YoY skyrocketed of 3,507.50% (in 2022) over the last 5 years.
  • Candel Therapeutics' Non-Current Debt (Yearly) stood at $560,000 in 2021, then surged by 3,507.50% to $20.2 million in 2022.